SCHEMBL17799748

SCHEMBL17799748

O=C(N[C@H]1CC[C@H]1c1ccc(F)cc1F)c1ccccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ TAS1R3 Q7RTX0 1/20 0.40
▸ TAS1R1 Q7RTX1 1/20 0.40
▸ TAS1R2 Q8TE23 1/20 0.40
▸ F2R P25116 1/20 0.40
▸ HCRTR1 O43613 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ HCRTR2 O43614 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CCR3 P51677 1/20 0.39
▸ ALPL P05186 1/20 0.39
▸ ALPI P09923 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17799692 0.89 HCRTR1 (0.49) NPC1ALDH1A1L3MBTL1TAS1R3TAS1R1
SCHEMBL17799656 0.86 HCRTR1 (0.50) NPC1ALDH1A1L3MBTL1TAS1R3TAS1R1
SCHEMBL17799733 0.86 HCRTR1 (0.50) NPC1ALDH1A1TAS1R3TAS1R1TAS1R2
SCHEMBL17799707 0.86 SIGMAR1 (0.42) L3MBTL1TAS1R3TAS1R1TAS1R2HCRTR1
SCHEMBL17799693 0.84 TAS1R3 (0.47) TAS1R3TAS1R1TAS1R2HCRTR1HCRTR2
SCHEMBL17799713 0.83 PPIA (0.41) TAS1R3TAS1R1TAS1R2HCRTR1HPGD
SCHEMBL17799638 0.82 HCRTR1 (0.54) HCRTR1HCRTR2MC1R
SCHEMBL17799706 0.81 TAS1R3 (0.39) NPC1ALDH1A1L3MBTL1TAS1R3TAS1R1
SCHEMBL17799747 0.81 TAS1R3 (0.39) NPC1L3MBTL1TAS1R3TAS1R1TAS1R2
SCHEMBL17799700 0.81 HCRTR1 (0.49) L3MBTL1TAS1R3TAS1R1TAS1R2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS NPC1 1078/4885ALDH1A1 1093/4885L3MBTL1 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback